7 years in prison (paroled after 6 years and 5 months)[1] $72 million in fines
YouTube information
Channel
Martin Shkreli
Genre(s)
Investing, finance
Subscribers
56.1 thousand[3][4]
Total views
1.76 million[4]
Last updated: May 01, 2024
Martin Shkreli (/ˈʃkrɛli/; born March 17, 1983) is an American financial criminal and businessman. Shkreli is the co-founder of the hedge funds Elea Capital, MSMB Capital Management, and MSMB Healthcare, the co-founder and former CEO of pharmaceutical firms Retrophin and Turing Pharmaceuticals, and the former CEO of start-up software company Gödel Systems, which he founded in August 2016.
In September 2015, Shkreli was widely criticized when Turing obtained the manufacturing license for the antiparasitic drug Daraprim and raised its price from US$13.50 to $750 per pill.
In 2017, Shkreli was charged and convicted in federal court on two counts of securities fraud and one count of conspiracy for activity unrelated to the Daraprim controversy. He was sentenced to seven years in prison and up to $7.4 million in fines. In the civil antitrust (monopoly abuse) case Shkreli was fined a further $64.6 million to be repaid to victims. On May 18, 2022, he was released early from the low-security federal prison in Allenwood, Pennsylvania.
^Merle, Renae (March 9, 2018). "Martin Shkreli sentenced to seven years in prison for defrauding investors". The Washington Post. ISSN 0190-8286. Archived from the original on March 9, 2018. Retrieved March 9, 2018.
^"No Friends To Celebrate With, Pharma-Bro Throws Himself Lonesome Online Birthday Party". Queerty. March 18, 2016. Archived from the original on July 30, 2018. Retrieved August 23, 2018.
^"Social Blade". Social Blade. March 16, 2023. Archived from the original on March 16, 2023. Retrieved May 1, 2024.
MartinShkreli (/ˈʃkrɛli/; born March 17, 1983) is an American financial criminal and businessman. Shkreli is the co-founder of the hedge funds Elea Capital...
three years in prison. In early 2016, MartinShkreli retained Brafman to defend him. In a 2017 jury trial, Shkreli was found guilty on two counts of securities...
fund manager MartinShkreli and his controversial monetary inflation of toxoplasmosis-related pharmaceuticals, it was revealed that Shkreli was a silent...
winning bidder was MartinShkreli, the CEO of Turing Pharmaceuticals, who paid a reported $2 million. In March 2018, following Shkreli's conviction for securities...
price dropped around 10% after the price increase of the drug. CEO MartinShkreli faced immense criticism for his actions. The company was named after...
liquidate their positions by contacting Falcone directly. In November 2015, MartinShkreli orchestrated a short squeeze on failed biotech KaloBios (KBIO) that...
Valley figures, including investors Marc Andreessen, Garry Tan, and MartinShkreli explicitly endorsed it by adding "e/acc" to their public social media...
Lesh Shkreli (born 1957), Albanian-American soccer player MartinShkreli (born 1983), American businessman and convicted felon Bernard Lown § Shkreli Awards...
program. Presentations from Retrophin, a company formerly headed by MartinShkreli, CEO of Turing, from which Turing acquired the rights to Daraprim, suggested...
Punch MartinShkreli in the Face, Figuratively". Forbes. Archived from the original on 2 December 2016. Retrieved 3 December 2016. "MartinShkreli responds...
folded after it was revealed that convicted pharmaceutical executive MartinShkreli was a major investor. The band formed sometime in April 2014 only a...
by Collect Records, which folded after the company severed ties with MartinShkreli who was revealed to be a silent investor in the label. All songs written...
Ferrer ('04), former Chairman of Metropolitan Transportation Authority MartinShkreli ('04), founder of Turing Pharmaceuticals Carl Heastie ('07), Speaker...
Espinoza, Joshua (May 13, 2016). "MartinShkreli Wants to Buy the Gun George Zimmerman Used to Kill Trayvon Martin". complex.com. "George Zimmerman: Gun...
Pharmaceuticals, Pharmasset, and MartinShkreli's Retrophin. In a 2023 speech and in his book Woke Inc., Ramaswamy called Shkreli, whose company had greatly...
various financial offenses, such as Sam Bankman-Fried, Caroline Ellison, MartinShkreli, and Do Kwon. The 30 Under 30 list has also drawn criticism, for under-recognition...
Global Information